1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Innovation and Discovery Grant is a grant from the American Association for Cancer Research (AACR) that funds cancer research projects focused on encouraging innovation and translating basic science discoveries into new treatment options for cancer. The program supports senior researchers developing novel ideas with the potential to improve cancer outcomes through translational approaches.
A recent funded example includes AI-driven spatial multiomics research to understand the tumor microenvironment in gastric cancer and identify biomarkers predictive of immunotherapy response. Eligible applicants are researchers focusing on innovative cancer research; specific eligibility criteria and award amounts are detailed in the program guidelines, which applicants should review directly through the AACR grants portal.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
AACR Innovation and Discovery Grant | Grants | AACR AACR Annual Meeting News: Read the Latest Session Previews from the Official News Website Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Patient / Caregivers / Public Researchers / Professionals AACR Innovation and Discovery Grant The AACR Innovation and Discovery Grant seeks to encourage innovation and translation of ideas from basic research into new treatment options for cancer.
Senior Associate Consultant II Jacksonville, Florida, USA AI driven spatial multimodal approaches to understand the tumor microenvironment in gastric cancer Dr. Hwang’s research focuses on enhancing the efficacy of immune checkpoint inhibitors (ICIs) in gastric cancer (GC) through AI-driven spatial analysis of the tumor microenvironment (TME).
Dr. Hwang proposes to identify biomarkers predictive of ICI response and discover actionable targets for improving treatment outcomes. Using AI algorithms to analyze multimodal spatial omics data, Dr. Hwang’s team will investigate the spatial heterogeneity and phenotypes of tumor, stroma, immune, and other types of cells in the TME.
This research could pave the way for personalized ICI therapy in GC and potentially improve the clinical benefit for patients. Dr. Hwang is a researcher specializing in the application of AI in oncology. He earned his doctorate in Computer Science from the University of Minnesota Twin-Cities after which he began his career at Genentech.
He later held a faculty position at the University of Texas Southwestern Medical Center, before joining the Cleveland Clinic in 2016. He currently serves as an endowed cancer chair at the Mayo Clinic, where he leads the AI in Oncology program. His interdisciplinary lab combines experimental techniques with AI methodologies to enhance the understanding and treatment of gastric cancer.
He and his team are dedicated to advancing the fields of predictive biomarkers and immunotherapy for this disease. Acknowledgment of Support “The 2024 AACR Innovation and Discovery Grant is crucial for advancing my research in developing AI-driven biomarkers for predicting immune checkpoint inhibitor responses in gastric cancer.
This support will significantly accelerate our efforts to improve patient outcomes and personalize cancer therapy. ” block needs to be placed in the location where the link block will be displayed--> The Progression of Cancer Professional Development Opportunities
According to the current listing, eligibility includes: Researchers focusing on innovative cancer research, as detailed in the program guidelines. Confirm the full requirements in the official notice before applying.
Innovation and Discovery Grant is funded by American Association for Cancer Research (AACR). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article